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Abstract
Background: Teenagers with allergies are at particular risk of severe and fatal reactions, but epinephrine auto-
injectors are not always carried as prescribed. We investigated barriers to carriage.
Methods: Patients aged 12-18 years old under a specialist allergy clinic, who had previously been prescribed an
auto-injector were invited to participate. Semi-structured interviews explored the factors that positively or
negatively impacted on carriage.
Results: Twenty teenagers with food or venom allergies were interviewed. Only two patients had used their auto-
injector in the community, although several had been treated for severe reactions in hospital. Most teenagers
made complex risk assessments to determine whether to carry the auto-injector. Most but not all decisions were
rational and were at least partially informed by knowledge. Factors affecting carriage included location, who else
would be present, the attitudes of others and physical features of the auto-injector. Teenagers made frequent risk
assessments when deciding whether to carry their auto-injectors, and generally wanted to remain safe. Their
decisions were complex, multi-faceted and highly individualised.
Conclusions: Rather than aiming for 100% carriage of auto-injectors, which remains an ambitious ideal,
personalised education packages should aim to empower teenagers to make and act upon informed risk
assessments.
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Background
Food allergy is common [1], affecting 2.3% of 11 to 15
year olds [2], and evidence suggests that the number of
severe food allergi cr e a c t i o n si si n c r e a s i n g[ 3 ] .I nt h e
UK there were 48 deaths from food allergy between
1999 and 2006 [4] with peanut and tree nut allergy
accounting for the majority of deaths. Although a pre-
vious history of anaphylaxis, asthma and peanut allergy
have been identified as risk factors for anaphylaxis, there
is no reliable way of predicting who will have a life-
threatening reaction. Teenagers are at particular risk
with the peak incidence of deaths from anaphylaxis
associated with peanut and tree nut allergy occurring in
the 15 to 24 age group [4]. First line treatment of
anaphylaxis in the community is intramuscular injection
of epinephrine (adrenaline) in the thigh [5] via an auto-
injector with administration of a second dose if the
symptoms persist or deteriorate.
Previous studies in our clinic suggest that teenagers
and young adults take risks when managing their aller-
gies [6-10]. They do not always carry their emergency
medication, eat foods labelled with “may contain” warn-
ings, and don’t tell the people around them about their
allergies. Absence of an auto-injector was found to be a
common factor in anaphylactic fatalities in USA [11].
Qualitative studies provide the depth of understanding
concerning experiences, thoughts and opinions of aller-
gic individuals [12] that is required to inform clinical
practice and intervention strategies. An in-depth study
has recently provided important insights into the bar-
riers to auto-injector use by teenagers recruited via pri-
mary care, a patient support group and a press release
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reproduction in any medium, provided the original work is properly cited.[13]; all were considered high risk for anaphylaxis and
patients were excluded if their reactions had been in
early childhood. The study identified multifaceted rea-
sons that prevent use of the auto-injectors, including
failure to recognise the severity of reaction, poor train-
ing regarding how to administer the dose, and failure to
carry the device. It is imperative that the auto-injector is
carried if there is any chance for it to be used. We
therefore focused on the attitudes of adolescents under
the care of a specialist paediatric allergy clinic that
might impact on whether they carry their prescribed
auto-injector.
Methods
Ethical approval was granted by Isle of Wight, Ports-
mouth and South East Hampshire Research Ethics Com-
mittee (LREC10/H0501/31). Informed consent and
assent was gained from parent and participant.
Participant Selection and Recruitment
Consecutive patients between 12 and 18 years old, who
had previously been prescribed an auto-injector were
interviewed prior to their routine clinic appointment or
whilst attending the day ward for immunotherapy at
Southampton University Hospitals NHS Trust (SUHT).
Decisions to prescribe an auto-injector were made by a
paediatric allergist on clinical lines broadly based on
EAACI guidelines [14],. Following the guidelines, the
majority of prescriptions were based on previous moder-
ate or severe reactions, but some teenagers received pre-
scriptions because of other risk factors, primarily peanut
or tree nut allergy in asthmatic patients, and insect
venom allergy in patients living remotely from medical
care. By 12 years participants will have had at least one
training session about anaphylaxis and auto-injectors,
aimed at them rather than their parents.
Questionnaire and Interview
Demographic data and information about their allergic
history was obtained in a short questionnaire completed
before the interview. The severity of a participant’s
worst ever reaction to was graded using a classification
previously used for peanut allergy [15]. All interviews
were conducted by one interviewer trained in qualitative
interview techniques. Interviews were conducted face-
to-face between the interviewer and teenager in a pri-
vate clinical area. One interview was conducted at a
bedside. The interviews were semi-structured, with a
prompt sheet containing areas to be covered, including
their allergic experiences, auto-injector carrying prac-
tices, and reasons for and against carriage. Interviews
were digitally recorded, anonymised and transcribed by
an experienced transcriber. Transcripts were checked
for accuracy by the interviewer before coding. Thematic
coding [16] was used to identify the main themes in the
data. The themes capture the main positions that the
participants took and include both areas of consensus
and difference between participants. The themes and
their interpretation were agreed between two of the
researchers (CM and JL) and agreed with the wider
research team. We had planned 20-30 interviews; there
was no significant development of the themes in the
analysis of the last three interviews, suggesting satura-
tion; we therefore conducted 20 interviews.
Literal transcriptions of selected relevant answers are
shown in Additional Files 1, 2, 3, 4, 5 (Box A-E). In
patient coding, F stands for female and M for male, fol-
lowed by the age of patient. “Ehrm” and “Er” are formu-
las used to express doubt, or hesitation.
Results
Twenty-three consecutive teenagers were approached
and 20 agreed to be interviewed between January and
April 2011 (10 males; average age 15.1 years). Two
declined because of time constraints and one on the
grounds that he “didn’t think it would be fun”.A l lb u t
two participants were interviewed alone, the exceptions
being for medical reasons. The allergic characteristics of
patients are summarised in Table 1.
Six themes relating to whether teenagers carried their
auto-injector were identified: role of circumstances, the
type of allergy, factors associated with device design, the
responsibility and attitude of others, and the teenager’s
feelings and concerns. Examples of quotes relating to
each theme are in Additional Files (Boxes A-E). There
were no notable differences in responses from patients
who had previously suffered severe reactions in compar-
ison to those who had experienced mild or moderate
reactions.
Role of Circumstances
All teenagers carried their auto-injector at least some of
the time, although one only if he was visiting the hospi-
tal to ‘keep the doctor happy’ (Additional file 1, Box
A;1). One participant said he always carried his auto-
injector (Additional file 1, Box A;2), but most teenagers
made decisions about whether to carry their medication,
based on the situation they found, or expected to find
themselves in. There were three elements of the context:
the place, the people involved and the perceived likeli-
hood of the presence of the allergen (Additional file 1,
Box A).
The place could be evaluated in terms of familiarity,
predictability and distance from auto-injector or external
help. Going to a friends’ house which was just next door
was considered to be low risk (Additional File 1, Box
A;3,4), and most considered keeping the auto-injector in
the changing rooms whilst on the sports field
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to eat. Going on holiday, to a restaurant or somewhere
unknown were considered high risk, and most would
take their auto-injectors when going to these places.
Almost all of the teenagers took their auto-injectors to
school, although a few didn’t ,c o n s i d e r i n gt h a ti tw a s
familiar and predictable environment and that they felt
in control. Social occasions like parties were a judge-
ment call on the part of the teenager, who would weigh
up the inconvenience of carrying the auto-injector
against the unpredictable nature of the event.
The teenagers also assessed the situation in relation to
who else was likely to be present (discussed in ‘Respon-
sibility of others’ section). Where the adult in charge
was not the legal guardian of the teenager, such as
friends parents and teachers, some teenagers said they
would be more likely to carry it.
The perceived likelihood of the presence of the aller-
gen was also very important, for example, food allergic
teenagers reported not worrying about going places
away from home if they were not expecting to eat any-
thing, for example walking the dog, or eating at a
friends’ house who knew to keep the allergen away from
them (Additional File 1, Box A;5,6).
Type of allergy
Food allergic teenagers had very different worries to
venom allergic teenagers (Additional File 2; Box B).
I n d i v i d u a l sw i t hf o o da l l e r g yw e r ea b l et oe x e r ts o m e
control by deciding whether to eat. Several participants
described a ‘hierarchy’ of food allergies, with peanut
allergy seen as the worst to have, and individuals with
allergies to fish and soya considering themselves at low
risk in comparison (Additional File 2, Box B;1,2). Indivi-
duals with venom allergy have no such control, although
the risk associated with venom allergy is seasonal, and
the teenagers did not consider themselves at much risk
in the winter (Additional File 2, Box B;3). Teenagers
with venom allergies were more wary of certain loca-
tions (Additional File 2, Box B;4), and were vigilant
about taking their auto-injectors to rural locations.
Attitudes about the device
Features of the device itself significantly impacted on its
carriage and acceptability for use (Additional File 3, Box
C). The physical features were the main consideration
and a large proportion of the teenagers commented that
the size of the device influenced their decision not to
carry it all of the time. The fact that the auto-injector is
too big to be carried in a pocket recurred as a major
issue, with boys mentioning it more than girls (Addi-
tional File 3, Box C;1). The needle and injection aspect
of using the auto-injector worried several of the teen-
agers, one of whom was so scared of it, that she said
she wouldn’t use it even if she was having a severe reac-
tion (Additional File 3, Box C;2). However, although fear
Table 1 Clinical characteristics of participants
Gender Age (Yrs.) Allergies Prescribed auto-
injector (years)
Ever used? Severity of worst reaction Age at 1
st
reaction (Yrs.)
F 16 Peanut, soya 9 No Mild/moderate 1
M 13 Peanut, brazil nut 8 No Severe 5
M 12 Wasp sting 1 No Mild 11
M 15 Egg 7 No Severe < 1
M 12 Cashew nut, hazelnut, strawberry 2 No Mild 5
F 16 Fish 10 No Moderate < 1
F 16 Peanut, brazil nut, hazelnut, pecan nut 10 Yes Severe unknown
M 16 Hornet sting 2 No Mild/moderate 15
M 14 Peanut, egg 10 No Moderate < 1
M 18 Brazil nut, grass, tree pollen 2 No Severe 16
M 12 Peanut 5 No Moderate/severe 7
F 16 Peanut, egg, dust mites 14 No Severe 1
F 17 Peanut, hazelnut, almonds 3 No Mild unknown
F 12 Peanut, sesame 7 No Mild 3
F 18 Wasp sting 4 No Mild 14
F 13 Peanut, brazil nut, cashew 7 No Severe 7
M 12 Milk, egg 8 No Severe < 1
F 16 All tree nuts except cashews 6 Yes Severe < 1
M 15 Horses, dogs < 1 No Severe 2
F 16 All nuts and peanuts unknown No Severe unknown
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reaction, there was no evidence from this study that it
affected carriage of devices.
Some teenagers suggested preferable alternatives to
injections such as an oral medication (Additional File 3,
Box C;3). The packaging was considered alarming and
scary by some, and the cardboard packaging was report-
edly too flimsy and easily battered when kept in a bag.
Almost all teenagers mentioned that it was irritating
having to remember to take the auto-injector every-
where with them and it would be easier not to have to
carry it. Some teenagers also mentioned other features
of the device, such as the expiry dates and the tempera-
ture liability as extra things to worry about.
The teenagers’ memories of their education regarding
their allergy and auto-injector affected how they thought
about and managed their situation. When asked to
demonstrate how to use the auto-injector, a minority of
the teenagers were unsure of how to do it in practise,
despite having received training from an allergy nurse
(Additional File 3, Box C;4,5). In contrast, many of the
teenagers easily remembered being taught in the clinic
how to use it, some regularly practised how to use
them, involving their family, and one had taught all of
their friends how to use it (Additional File 3, Box C;6).
Most of the teenagers knew what to expect from a reac-
tion, and what symptoms would prompt them to take
either anti-histamines or use the auto-injector.
Responsibility and attitudes of others
Whilst some of the teenagers managed their auto-injec-
tors relatively independently, many relied on other peo-
ple to shoulder the responsibility of carrying the auto-
injector, ensuring it was in date and administering it if
needed (Additional File 4, Box D). Independence did
improve with age, and boys were more reliant than girls.
The person most relied on was the mother (Additional
File 4, Box D;1,2,3) but also the school nurse, father and
teachers. When someone else was in charge of an aspect
of managing the allergy, some mentioned that they
didn’t have to think about their allergy, so felt less
concerned.
The attitudes of friends influenced the way teenagers
perceived and managed their allergy. A few teenagers
reported that members of their family or friends also
had allergies, and this made it more acceptable for them
(Additional File 4, Box D;4). Others had friends who
had no understanding of allergies, who saw the auto-
injector as something to make fun of, play around with
or even steal (Additional File 4, Box D;5,6).
Positive reactions by others tended to increase the
acceptance of their auto-injector, e.g. others learning
how to use the auto-injector, being aware of their
allergy, and not making a big deal out of it made the
teenagers feel more comfortable with carrying their
auto-injector (Additional File 4, Box D;7).
Feelings and attitudes of allergic teenagers to auto-
injectors
The way the teenagers felt about their auto-injectors
was influenced by the interactions of factors from the
previously mentioned themes. For example, a teenager
whose parents carry the auto-injector for them most of
the time would be less bothered by the size or shape of
it, but may be less sure how to use it.
Some teenagers’ concerns about the dangers of allergy
manifest as stronger adherence to medical advice which
created a sense of safety (Additional File 5, Box E;1).
Other emotions could prevent carriage, for example
embarrassment or “it won’th a p p e nt om e ” type-invinci-
bility (Additional File 5, Box E;2,3). Some participants
balanced their negative feelings against the perceived
advantages of having the correct treatment (Additional
File 5, Box E;4,5). For others the auto-injector was not
considered a problem, just a normal part of life (Addi-
tional File 5, Box E;6).
Many teenagers commented that it was irritating to
have to carry their auto-injector everywhere, but this did
not affect how much they actually carried it. Most were
aware that it was given to them for a very good reason,
it was their ‘lifeline’ and although it was a pain, there
wasn’tm u c ht h a tc o u l db ed o n ea b o u ti t( A d d i t i o n a l
File 5, Box E;5.6). Some teenagers felt embarrassed by
having to carry it, or did not want any extra attention
because of it, but were able to deal with these emotions
and did not let them affect their actions.
Discussion
This is the first study to investigate factors and feelings
that may inhibit or improve the carriage of epinephrine
auto-injectors by teenagers under the care of a specialist
allergy clinic. Although teenagers with food or venom
allergy are generally in excellent health, the constant
need for avoidance of allergen exposure and need to
carry rescue medication impact on quality of life [17]. It
was notable that the majority of teenagers wanted to
remain safe and made risk assessments taking into
account a number of factors including the likelihood of
contact with an allergen and who else would be present
to assist them should they have a reaction.
Our main finding was that adolescents are not making
decisions with respect to their auto-injector that are
especially irrational or hard to understand. They do
however vary considerably in their approach to risk
assessment and their auto-injector and live in a state of
considerable uncertainty. More education about risk and
risk assessment might be empowering for this group. A
second key finding was adolescents’ dissatisfaction with
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sions not to carry the auto-injector were based on the
physical design of the auto-injector and the hassles of
carrying it, rather than informed risk assessments.
Thirdly, most decision making was rational, although
some decision making was based on rules of thumb that
they had derived themselves rather than through medi-
cal advice or other reputable forms of information.
All participants were under specialist allergy services.
It is our usual management that in addition to a medical
and, where appropriate, dietetic review, the parents of
younger children have one-to-one auto-injector counsel-
ling and training from an allergy nurse, are provided
with personal written management plans and have leaf-
lets concerning allergen avoidance and auto-injectors.
Prior to secondary education we aim to repeat this edu-
cation package for the child, almost invariably with the
parent present. All participants had received such train-
ing. Through the teenage years we aim to gradually
transition the patient to management independent of
their parents [10].
We have previously shown that teenagers take risks
when managing their allergies and a number of surveys
have also shown that teenagers do not carry their auto-
injectors at all times and eat foods that incur risks (5-9).
Only one of the participants in the study reported carry-
ing their auto-injector at all times; most would continu-
ally assess the possible risk of exposure to the allergen
and whether or not they felt the need to carry the
device. It is unlikely that any educational package could
achieve 100% carriage of auto-injectors by teenagers and
a more pragmatic approach is to empower them to
make safe risk assessments eg. knowledge of the overall
level of risk for mild reactions/severe reactions/fatal ana-
phylaxis in adolescents with food allergies, and an
understanding of personal risk factors which might
impact on this.
Although some of the teenagers expressed feelings
about their allergies such as fear or anxiety, this did not
necessarily improve adherence to carry their auto-injec-
tor. This finding supports a previous study on children
and mothers in our clinic, which found that anxiety did
not improve adherence to medical advice [8]. However
in some cases the anxiety did appear to promote car-
riage and as noted in previous studies, the burden of
allergy in teenagers seems to be relieved by having an
auto-injector prescribed [8,18].
We found that many younger teenagers relied on their
parents or teachers to take care of them should they
have a reaction but this reliance on others appeared to
diminish with increasing age. This is aligned with the
educational programme of gradual transition of care in
our clinic, in which the parents are initially totally
responsible for the allergen avoidance and medical care
of a very young child, with increasing independence of
the child throughout childhood to a state in which they
should be fully independent by the time that they trans-
fer to adult services. However parents continue to pro-
vide support even for older teenagers and this might
improve adherence with carriage and treating reactions
[19]. It is noteworthy that all of the teenagers in the
study were accompanied to the hospital by at least one
parent.
Some of the participants in the study reported that
their peers were well informed about their allergy and
knew what to do should they have a reaction. These
individuals seemed calmer about the prospect of a reac-
tion. In peer-led asthma education programmes for ado-
lescents participants have reported feeling more
comfortable with their condition when their friends
understood it [20].
Only two of the participants in the study had ever
personally used their auto-injector although a number
had been injected with epinephrine by a health profes-
sional. We ensure that all teenagers in the clinic have
the opportunity to practice using a trainer auto-injector
and also aim for them all at some stage during their
time in our clinic to have used a ‘live’ auto-injector into
a fruit or vegetable. Not all participants in this study
had had the opportunity to use a ‘live’ auto-injector. It
is clearly paramount that not only is the auto-injector
carried but it is used appropriately either by the allergic
individual themselves or by one of their friends and
peer education is therefore of vital importance [13].
A major factor cited by most teenagers was the size
and shape of their auto-injector and the presence of a
needle was also predominant in some patients’ decision
as to whether they should use it. The auto-injector can
only be used if it is being carried and it is vital that con-
sideration is given to designing devices that are more
acceptable and practical to be carried [21]. The packa-
ging used to protect devices in situations where it is car-
ried in a bag needs addressing to ensure that it is
robust. Patients should be provided with information for
them to obtain the hard cases that are commercially
available.
Our findings compliment a primary care study by Gal-
lagher et al [13] which investigated teenagers’ attitudes
and knowledge about their auto-injector, allowing com-
parisons between respondents who have received differ-
ent allergy care packages. Our study has very different
findings, presumably reflecting that our participants
were under the care of a specialist centre and had
received much of the education proposed by the pre-
vious study. Despite most of them having an acceptable
level of knowledge regarding device usage, most
described a physical and psychological barriers to car-
riage that need addressing.
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Our study demonstrates that the reasons for teenagers
not carrying or using their epinephrine auto-injectors
are multifaceted and complex. Despite being under the
care of a specialist allergy clinic and having undergone a
longitudinal educational programme, a number of deci-
sions made by teenagers were based on the physical
design of the device and the hassles of carrying it, rather
than informed risk assessments. It is noteworthy that
the majority of teenagers wanted to remain safe and
generally made rational risk assessments. All of our
teenagers have been trained in the use of epinephrine
auto-injectors but unless they are actually carrying them
at the time of a reaction, the risk of fatality increases.
Our study highlights the need for individualised discus-
sions regarding risk management. A single educational
intervention is unlikely to work since the beliefs, emo-
tions and lifestyle of each teenager is different and this
impacted on their carriage and likelihood of using their
auto-injector. We call on product designers and phar-
maceutical companies to work on developing devices
that are more acceptable to our patients and easier to
carry, and from health care professionals to provide
individualised educational packages for allergic
teenagers.
Additional material
Additional file 1: Box A. Quotes from participants. Legend for Boxes:
Quotes are labelled as sex and age in years. Gender M = male; F =
female. Direct quotes from participants are included. “Ehrm” and “Er” are
formulas used to express doubt, or hesitation. Where a commercial name
of a device was used the text has been amended to “auto-injector”.
Additional file 2: Box B. Quotes from participants. Legend for Boxes:
Quotes are labelled as sex and age in years. Gender M = male; F =
female. Direct quotes from participants are included. “Ehrm” and “Er” are
formulas used to express doubt, or hesitation. Where a commercial name
of a device was used the text has been amended to “auto-injector”.
Additional file 3: Box C. Quotes from participants. Legend for Boxes:
Quotes are labelled as sex and age in years. Gender M = male; F =
female. Direct quotes from participants are included. “Ehrm” and “Er” are
formulas used to express doubt, or hesitation. Where a commercial name
of a device was used the text has been amended to “auto-injector”.
Additional file 4: Box D. Quotes from participants. Legend for Boxes:
Quotes are labelled as sex and age in years. Gender M = male; F =
female. Direct quotes from participants are included. “Ehrm” and “Er” are
formulas used to express doubt, or hesitation. Where a commercial name
of a device was used the text has been amended to “auto-injector”.
Additional file 5: Box E. Quotes from participants. Legend for Boxes:
Quotes are labelled as sex and age in years. Gender M = male; F =
female. Direct quotes from participants are included. “Ehrm” and “Er” are
formulas used to express doubt, or hesitation. Where a commercial name
of a device was used the text has been amended to “auto-injector”.
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